Now: Essential Medicines
Download
Report
Transcript Now: Essential Medicines
Essential Medicines Programmes
Sudan
now
Now: Essential Medicines programmes
In 2010 , health expenditures
• The public per capita expenditure is US$ 40,
Now: NDP
• The NDP is increasingly act as a framework for
managing the pharmaceutical sector.
Now: Essential Medicines
• It guides the procurement of medicines in the public
sector, health insurance, donations, and local
medicine production.
• It is part of training programme of graduated
pharmacists.
• Today, both public tender prices and C&F prices for
private sector are publically available in websites.
Now: Public Supply System
• Management system improved significantly
– Computerized system at central
– SOPs and adherence to basic standards in drug
supply management
– Monitoring and evaluation systems,
– Managerial auditing system
• Delivery to states through RDF project
– Branch in each state with 8% less in price;
Now: Health Insurance
– Coverage is only 30% of population;
– Based on essential medicines;
– Patient pay 25% of the treatment cost;
– Branch in each state
Now: Health Partners
• Obtaining health partners and donors support to
expand the drug supply & management
component;
– GF delivering free medicines for the TB, HIV and
Malaria
– programmes for control neglected and communicable
diseases e.g Meningitis outbreaks,
– EPI,
– RH
• EHA, in areas where the Government is not
available
Now: Availability
• In 2007, the availability essential medicines in public
sector was 86% and 95% in private sector
• In 2010, availability of essential medicines at public
sector was 80.6%, and in private sector was 93.0%
In 2007, only 67 % are affordable.
Now: RUM
• In 2007; 73% of prescribed medicines in public
sector were from the EML,
• 45% were prescribed by generic name
Now: Regulations essential medicines
• In 2007, independent MRA was established
and Policies separated from regulations;
• With support of WHO/EC roadmap for QC PQ
is in place since 2008.
• Pharmaco-vigilance unit established in 2009;
• Being Uppsala member supported by EC
Other changes
• WHO Good Governance started in 2010
• Pharmaceutical Country Profile, in 2010
• Global Fund Project for 5-years support
• Licensed pharmacists was 1.53/10,000
compared to 0.5/10,000 in 1990,
• HR mapping was conducted
– framework for HRD developed;
Challenges
1. Fragmented health system, with inequitable distribution of
resources;
–
Verticality of supplies by different programme
2. Instability of policies towards public supply system;
3. Poor data and information management system;
4. Efficacy and quality, yet is a question;
5. Distribution and delivery at state level;
6. Accessibility is still low;
7. Low coverage of health insurance;
8. Irrational use of medicines (36% of health expenditures);
9. Capacities to adsorb all available budgets is limited;
10. Policies implementation and monitoring
Thank you